
J Neuropsychiatry Clin Neurosci 15:306-316, August 2003
© 2003 American Psychiatric Press, Inc.
The Extended Amygdala and the Dopamine System: Another Piece of the Dopamine Puzzle
Julie L. Fudge, M.D. and
Ana B. Emiliano, M.D.
Received January 8, 2002; revised May 2, 2002; accepted May 7, 2002. From the Departments of Psychiatry, Neurobiology and Anatomy, and Medicine, University of Rochester Medical Center, Rochester, New York. Address correspondence to Dr. Julie Fudge, Departments of Psychiatry and Neurobiology and Anatomy, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Julie_Fudge{at}urmc.rochester.edu (E-mail).
The dopamine (DA) system has long been associated with the pathophysiology of psychosis. The DA theory of schizophrenia continues to find support in neuroreceptor imaging and ligand-binding studies that show excess DA transmission in patients, as compared to controls. The pathways that regulate the primate DA system, however, have yet to be fully elucidated. The amygdala, including its extended amygdala component, is involved in evaluating the emotional value of sensory stimuli. Since emotionally relevant sensory stimuli are distorted during psychotic episodes, we hypothesize that amygdaloid influences are likely to be significant modulators of the DA system. We reviewed evidence for direct projections from the central extended amygdala to specific subpopulations of DA neurons, and we discuss how these pathways may serve as important conduits of emotionally relevant information that can have immediate and long-term effects on DA regulation.
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Fricchione, S. H. Nejad, J. A. Esses, T. J. Cummings Jr., J. Querques, N. H. Cassem, and G. B. Murray
Postoperative Delirium
Am J Psychiatry,
July 1, 2008;
165(7):
803 - 812.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Michalopoulou, S. Surguladze, L. A. Morley, V. P. Giampietro, R. M. Murray, and S. S. Shergill
Facial fear processing and psychotic symptoms in schizophrenia: functional magnetic resonance imaging study
The British Journal of Psychiatry,
March 1, 2008;
192(3):
191 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kumakura, P. Cumming, I. Vernaleken, H.-G. Buchholz, T. Siessmeier, A. Heinz, T. Kienast, P. Bartenstein, and G. Grunder
Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study
J. Neurosci.,
July 25, 2007;
27(30):
8080 - 8087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Remy, M. Doder, A. Lees, N. Turjanski, and D. Brooks
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
Brain,
June 1, 2005;
128(6):
1314 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Shaw, J Mellers, M Henderson, C Polkey, A S David, and B K Toone
Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors
J. Neurol. Neurosurg. Psychiatry,
July 1, 2004;
75(7):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2003
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|